Search
This is a protocol for a Cochrane Review (intervention). The objectives were to assess the efficacy and safety of whole‐cell pertussis (wP) vaccinations in comparison to acellular pertussis (aP) vaccinations in early infancy for the prevention of atopic diseases in children.
These findings suggest that genetic variants at the VDR locus may play a role in acute wheeze/asthma severity in children
We demonstrate that NOTCH3 is a regulator of MUC5AC production
The expression pattern of FcεRI on DC and basophils differentiates asthmatic from non-asthmatic atopic children
These findings suggest the utility of specific FOT outcomes is dependent on the respiratory disease being assessed
Type 1 and 3 interferon response capacity appears strongly developmentally constrained at birth
An ambitious project that could stop children developing asthma is the centrepiece of a new world-class respiratory research centre launched in Perth.
Researchers developing a world-first treatment that targets an underlying cause of asthma have secured a $499,640 grant from the Future Health, Research and Innovation Fund – Innovation Seed Fund.
A collaboration between The Kids Research Institute Australia and Joondalup Health Campus is poised to be a game-changer for early childhood development.
The way the immune system operates differs between males and females. This is due to both differential expression of immune-related genes from the sex chromosomes as well as the immune modulatory properties of sex hormones. Together, these effects contribute to a skewed prevalence of disease and disease course between males and females, including allergic-, infectious-, autoimmune-, and cancerous disease.